文献
J-GLOBAL ID:202102289185105418
整理番号:21A0384025
転移性去勢抵抗性前立腺癌に対するゲノム試験指向オラパリブの費用対効果【JST・京大機械翻訳】
Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
著者 (3件):
Su Dan
(Department of Pharmacy, the First Affiliated Hospital of University of Science and Technology of China, Hefei 230001, Anhui, China)
,
Wu Bin
(Medical Decision and Economic Group, Ren Ji Hospital, South Campus, School of Medicine, Shanghai Jiaotong University, Shanghai, China)
,
Shi Lizheng
(Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, United States)
資料名:
Frontiers in Pharmacology (Web)
(Frontiers in Pharmacology (Web))
巻:
11
ページ:
610601
発行年:
2020年
JST資料番号:
U7091A
ISSN:
1663-9812
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)